Canal-U

Mon compte

Résultats de recherche

Nombre de programmes trouvés : 21
Conférences

le (58m17s)

Cardiovascular Clinical Trialists (CVCT) Forum – Paris 2012 - Workshop 5 : Will we be able to answer the question of HDL as a therapeutic target after the CETP inhibitor trials? (Robert ROSENSON)

... New York, USAIdentifying new targets: The value of omics and mendelian randomization studiesSpeaker: Juan Pablo CASAS, London, GBRIdentifying new targets: Monoclonal Antibody Inhibitor of PCSK9Speakers: Wolfgang KOENIG, Ulm, GER - Robert SCOTT, Amgen,...
Voir la vidéo

 
FMSH
 
Facebook Twitter Google+
Mon Compte